Evidence map›Paper›PMID 33812462›Full record

ArticleParasite (Paris, France)2021

Efficacy of a novel topical combination of esafoxolaner, eprinomectin and praziquantel for the prevention of heartworm disease in cats.

Christine Baker, John McCall, Abdelmoneim Mansour, Scott McCall, Tayna Shaffer, Kenneth Wakeland, Elizabeth Mitchell, Justin Frost, Eric Tielemans, Dwight Bowman

Open access · goldAbstract readRandomized Controlled Trial, Veterinary
PubMed Full text at PMC Publisher
In one paragraph

Article in Parasite (Paris, France), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Prevalence of Lungworm Infections in Hedgehogs (Pathogens (Basel, Switzerland) · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Christine BakerBoehringer-Ingelheim Animal Health, 1730 Olympic Drive, Athens, 30601 GA, USA.
John McCallTRS Labs Inc., 215 Paradise Blvd, Athens, 30607-1151 GA, USA.
Abdelmoneim MansourTRS Labs Inc., 215 Paradise Blvd, Athens, 30607-1151 GA, USA.
Scott McCallTRS Labs Inc., 215 Paradise Blvd, Athens, 30607-1151 GA, USA.
Tayna ShafferClinVet USA, 1479 Talmadge Hill Rd S, Waverly, 14892 NY, USA.
Kenneth WakelandBoehringer-Ingelheim Animal Health, 1730 Olympic Drive, Athens, 30601 GA, USA.
Elizabeth MitchellBoehringer-Ingelheim Animal Health, 1730 Olympic Drive, Athens, 30601 GA, USA.
Justin FrostBoehringer-Ingelheim Animal Health, 1730 Olympic Drive, Athens, 30601 GA, USA.
Eric TielemansBoehringer-Ingelheim Animal Health, 29 Avenue Tony Garnier, 69007 Lyon, France.ORCID 0000-0003-4798-3246
Dwight BowmanCollege of Veterinary Medicine, Cornell University, Ithaca, 14850 NY, USA.
Boehringer Ingelheim (United States) · USTRS Technologies (United States) · USCornell University · USDépartement Santé Animale · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

NexGard

Indexed as

Cat DiseasesDirofilaria immitisDirofilariasisAnimalsCatsIvermectinPraziquanteleprinomectinIvermectinPraziquantelCatDirofilaria immitisEfficacyEprinomectinHeartworm disease

Identifiers

PMID33812462
PMCPMC8019556
OpenAlexW3142112039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.